Maria Teresa B Abola1, Jonathan Golledge2, Tetsuro Miyata3, Seung-Woon Rha4, Bryan P Yan5, Timothy C Dy6, Marie Simonette V Ganzon7, Pankaj Kumar Handa8, Salim Harris9, Jiang Zhisheng10, Ramakrishna Pinjala11, Peter Ashley Robless12, Hiroyoshi Yokoi13, Elaine B Alajar14, April Ann Bermudez-Delos Santos15, Elmer Jasper B Llanes16, Gay Marjorie Obrado-Nabablit15, Noemi S Pestaño15, Felix Eduardo Punzalan17, Bernadette Tumanan-Mendoza18. 1. Department of Clinical Research, Philippine Heart Center and University of the Philippines College of Medicine. 2. Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, and Department of Vascular and Endovascular Surgery, The Townsville Hospital. 3. Vascular Center, Sanno Hospital and Sanno Medical Center. 4. Dept of Cardiology, Internal Medicine, College of Medicine, Korea University; Cardiovascular Center, Korea University Guro Hospital. 5. Division of Cardiology, Department of Medicine and Therapeutics,The Chinese University of Hong Kong, Prince of Wales Hospital. 6. The Heart Institute, Chinese General Hospital and Medical Center. 7. Dr. HBCalleja Heart and Vascular Institute, St. Luke's Medical Center. 8. Department of General Medicine, Tan Tock Seng Hospital. 9. Neurovascular and Neurosonology Division, Neurology Department, Universitas Indonesia, Cipto Mangunkusumo General Hospital. 10. University of South China. 11. Apollo Hospitals. 12. Robless Vascular Clinic. 13. Cardiovascular Center, Fukuoka Sanno Hospital; International University of Health and Welfare. 14. Section of Cardiology, Department of Internal Medicine, Manila Doctors Hospital; University of the Philippines College of Medicine. 15. Section of Cardiology, Department of Internal Medicine, Manila Doctors Hospital. 16. Division of Cardiology, Department of Medicine, College of Medicine, University of the Philippines Philippine General Hospital. 17. Division of Cardiology, Department of Medicine, College of Medicine, University of the Philippines; Philippine General Hospital. 18. Department of Clinical Epidemiology, University of the Philippines College of Medicine.
Abstract
BACKGROUND: Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and therapeutic modalities, and even patient treatment response. The Asian Pacific Society of Atherosclerosis and Vascular Diseases (APSAVD) thus coordinated the development of an Asia-Pacific Consensus Statement (APCS) on the Management of PAD. OBJECTIVES: The APSAVD aimed to accomplish the following: 1) determine the applicability of the 2016 AHA/ACC guidelines on the Management of Patients with Lower Extremity Peripheral Artery Disease to the Asia-Pacific region; 2) review Asia-Pacific literature; and 3) increase the awareness of PAD. METHODOLOGY: A Steering Committee was organized to oversee development of the APCS, appoint a Technical Working Group (TWG) and Consensus Panel (CP). The TWG appraised the relevance of the 2016 AHA/ACC PAD Guideline and proposed recommendations which were reviewed by the CP using a modified Delphi technique. RESULTS: A total of 91 recommendations were generated covering history and physical examination, diagnosis, and treatment of PAD-3 new recommendations, 31 adaptations and 57 adopted statements. This Asia-Pacific Consensus Statement on the Management of PAD constitutes the first for the Asia-Pacific Region. It is intended for use by health practitioners involved in preventing, diagnosing and treating patients with PAD and ultimately the patients and their families themselves.
BACKGROUND:Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and therapeutic modalities, and even patient treatment response. The Asian Pacific Society of Atherosclerosis and Vascular Diseases (APSAVD) thus coordinated the development of an Asia-Pacific Consensus Statement (APCS) on the Management of PAD. OBJECTIVES: The APSAVD aimed to accomplish the following: 1) determine the applicability of the 2016 AHA/ACC guidelines on the Management of Patients with Lower Extremity Peripheral Artery Disease to the Asia-Pacific region; 2) review Asia-Pacific literature; and 3) increase the awareness of PAD. METHODOLOGY: A Steering Committee was organized to oversee development of the APCS, appoint a Technical Working Group (TWG) and Consensus Panel (CP). The TWG appraised the relevance of the 2016 AHA/ACCPAD Guideline and proposed recommendations which were reviewed by the CP using a modified Delphi technique. RESULTS: A total of 91 recommendations were generated covering history and physical examination, diagnosis, and treatment of PAD-3 new recommendations, 31 adaptations and 57 adopted statements. This Asia-Pacific Consensus Statement on the Management of PAD constitutes the first for the Asia-Pacific Region. It is intended for use by health practitioners involved in preventing, diagnosing and treating patients with PAD and ultimately the patients and their families themselves.
Authors: Kristy Pickwell; Volkert Siersma; Marleen Kars; Jan Apelqvist; Karel Bakker; Michael Edmonds; Per Holstein; Alexandra Jirkovská; Edward Jude; Didac Mauricio; Alberto Piaggesi; Gunnel Ragnarson Tennvall; Heinrich Reike; Maximilian Spraul; Luigi Uccioli; Vilma Urbancic; Kristien van Acker; Jeff van Baal; Nicolaas Schaper Journal: Diabetes Care Date: 2015-02-09 Impact factor: 19.112
Authors: Aljoscha Rastan; Gunnar Tepe; Hans Krankenberg; Rainer Zahorsky; Ullrich Beschorner; Elias Noory; Sebastian Sixt; Thomas Schwarz; Klaus Brechtel; Catherine Böhme; Franz-Josef Neumann; Thomas Zeller Journal: Eur Heart J Date: 2011-05-26 Impact factor: 29.983
Authors: Karl-Ludwig Schulte; Ernst Pilger; Sebastian Schellong; Kong Ten Tan; Frederic Baumann; Ralf Langhoff; Giovanni Torsello; Thomas Zeller; Klaus Amendt; Marianne Brodmann Journal: J Endovasc Ther Date: 2015-08-05 Impact factor: 3.487